| Spike mutation D614G alters SARS-CoV-2 fitness JA Plante, Y Liu, J Liu, H Xia, BA Johnson, KG Lokugamage, X Zhang, ... Nature 592 (7852), 116-121, 2021 | 1645 | 2021 |
| Evasion of type I interferon by SARS-CoV-2 H Xia, Z Cao, X Xie, X Zhang, JYC Chen, H Wang, VD Menachery, ... Cell reports 33 (1), 2020 | 840 | 2020 |
| Neutralization of SARS-CoV-2 spike 69/70 deletion, E484K and N501Y variants by BNT162b2 vaccine-elicited sera X Xie, Y Liu, J Liu, X Zhang, J Zou, CR Fontes-Garfias, H Xia, ... Nature medicine 27 (4), 620-621, 2021 | 638 | 2021 |
| Neutralizing activity of BNT162b2-elicited serum Y Liu, J Liu, H Xia, X Zhang, CR Fontes-Garfias, KA Swanson, H Cai, ... New England Journal of Medicine 384 (15), 1466-1468, 2021 | 636 | 2021 |
| SARS-CoV-2 neutralization with BNT162b2 vaccine dose 3 AR Falsey, RW Frenck Jr, EE Walsh, N Kitchin, J Absalon, A Gurtman, ... New England Journal of Medicine 385 (17), 1627-1629, 2021 | 379 | 2021 |
| Delta spike P681R mutation enhances SARS-CoV-2 fitness over Alpha variant Y Liu, J Liu, BA Johnson, H Xia, Z Ku, C Schindewolf, SG Widen, Z An, ... Cell reports 39 (7), 2022 | 362 | 2022 |
| BNT162b2-elicited neutralization of B. 1.617 and other SARS-CoV-2 variants J Liu, Y Liu, H Xia, J Zou, SC Weaver, KA Swanson, H Cai, M Cutler, ... Nature 596 (7871), 273-275, 2021 | 342 | 2021 |
| Low neutralization of SARS-CoV-2 Omicron BA. 2.75. 2, BQ. 1.1 and XBB. 1 by parental mRNA vaccine or a BA. 5 bivalent booster C Kurhade, J Zou, H Xia, M Liu, HC Chang, P Ren, X Xie, PY Shi Nature medicine 29 (2), 344-347, 2023 | 308 | 2023 |
| An evolutionary NS1 mutation enhances Zika virus evasion of host interferon induction H Xia, H Luo, C Shan, AE Muruato, BTD Nunes, DBA Medeiros, J Zou, ... Nature communications 9 (1), 414, 2018 | 288 | 2018 |
| Neutralization of N501Y mutant SARS-CoV-2 by BNT162b2 vaccine-elicited sera PY Shi, X Xie, J Zou, C Fontes-Garfias, H Xia, K Swanson, M Cutler, ... Research square, 2021 | 176 | 2021 |
| Ubiquitination of SARS-CoV-2 ORF7a promotes antagonism of interferon response Z Cao, H Xia, R Rajsbaum, X Xia, H Wang, PY Shi Cellular & molecular immunology 18 (3), 746-748, 2021 | 112 | 2021 |
| Neutralization against Omicron SARS-CoV-2 from previous non-Omicron infection J Zou, H Xia, X Xie, C Kurhade, RRG Machado, SC Weaver, P Ren, ... Nature communications 13 (1), 852, 2022 | 107 | 2022 |
| BNT162b2-elicited neutralization against new SARS-CoV-2 spike variants Y Liu, J Liu, H Xia, X Zhang, J Zou, CR Fontes-Garfias, SC Weaver, ... New England Journal of Medicine 385 (5), 472-474, 2021 | 104 | 2021 |
| Envelope protein ubiquitination drives entry and pathogenesis of Zika virus MI Giraldo, H Xia, L Aguilera-Aguirre, A Hage, S van Tol, C Shan, X Xie, ... Nature 585 (7825), 414-419, 2020 | 96 | 2020 |
| Human Enterovirus Nonstructural Protein 2CATPase Functions as Both an RNA Helicase and ATP-Independent RNA Chaperone H Xia, P Wang, GC Wang, J Yang, X Sun, W Wu, Y Qiu, T Shu, X Zhao, ... PLoS pathogens 11 (7), e1005067, 2015 | 95 | 2015 |
| Neutralization and durability of 2 or 3 doses of the BNT162b2 vaccine against Omicron SARS-CoV-2 H Xia, J Zou, C Kurhade, H Cai, Q Yang, M Cutler, D Cooper, A Muik, ... Cell Host & Microbe 30 (4), 485-488. e3, 2022 | 77 | 2022 |
| Neutralization of Omicron BA. 1, BA. 2, and BA. 3 SARS-CoV-2 by 3 doses of BNT162b2 vaccine C Kurhade, J Zou, H Xia, H Cai, Q Yang, M Cutler, D Cooper, A Muik, ... Nature communications 13 (1), 3602, 2022 | 70 | 2022 |
| Zika virus NS2A-mediated virion assembly X Zhang, X Xie, H Xia, J Zou, L Huang, VL Popov, X Chen, PY Shi MBio 10 (5), 10.1128/mbio. 02375-19, 2019 | 66 | 2019 |
| A Zika virus envelope mutation preceding the 2015 epidemic enhances virulence and fitness for transmission C Shan, H Xia, SL Haller, SR Azar, Y Liu, J Liu, AE Muruato, R Chen, ... Proceedings of the National Academy of Sciences 117 (33), 20190-20197, 2020 | 62 | 2020 |
| Evasion of type I interferon by SARS-CoV-2. Cell Rep 33: 108234 H Xia, Z Cao, X Xie, X Zhang, JYC Chen, H Wang, VD Menachery, ... | 62 | 2020 |
